Morgan Stanley’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $457M | Sell |
10,702,527
-1,809,340
| -14% | -$80.8M | 0.02% | 614 |
|
|
2026
Q1 | $603M | Buy |
12,511,867
+3,409,671
| +37% | +$159M | 0.04% | 470 |
|
|
2025
Q4 | $441M | Buy |
9,102,196
+1,540,271
| +20% | +$76.4M | 0.03% | 577 |
|
|
2025
Q3 | $357M | Sell |
7,561,925
-695,721
| -8% | -$33.6M | 0.02% | 651 |
|
|
2025
Q2 | $399M | Buy |
8,257,646
+246,642
| +3% | +$12.6M | 0.03% | 582 |
|
|
2025
Q1 | $444M | Sell |
8,011,004
-2,073,781
| -21% | -$112M | 0.03% | 511 |
|
|
2024
Q4 | $486M | Sell |
10,084,785
-7,690,548
| -43% | -$391M | 0.03% | 483 |
|
|
2024
Q3 | $1.02B | Buy |
17,775,333
+3,041,391
| +21% | +$164M | 0.07% | 245 |
|
|
2024
Q2 | $715M | Buy |
14,733,942
+5,377,796
| +57% | +$259M | 0.06% | 314 |
|
|
2024
Q1 | $455M | Buy |
9,356,146
+1,487,666
| +19% | +$72.6M | 0.04% | 472 |
|
|
2023
Q4 | $391M | Buy |
7,868,480
+545,674
| +7% | +$26.7M | 0.03% | 501 |
|
|
2023
Q3 | $393M | Buy |
7,322,806
+323,968
| +5% | +$17.3M | 0.04% | 444 |
|
|
2023
Q2 | $377M | Sell |
6,998,838
-891,805
| -11% | -$48M | 0.04% | 461 |
|
|
2023
Q1 | $429M | Buy |
7,890,643
+157,574
| +2% | +$7.66M | 0.05% | 402 |
|
|
2022
Q4 | $375M | Buy |
7,733,069
+1,251,199
| +19% | +$54.9M | 0.04% | 436 |
|
|
2022
Q3 | $246M | Buy |
6,481,870
+371,680
| +6% | +$16.6M | 0.03% | 494 |
|
|
2022
Q2 | $306M | Buy |
6,110,190
+3,716,445
| +155% | +$197M | 0.04% | 440 |
|
|
2022
Q1 | $123M | Sell |
2,393,745
-1,256,208
| -34% | -$64.9M | 0.02% | 748 |
|
|
2021
Q4 | $183M | Buy |
3,649,953
+1,334,648
| +58% | +$66M | 0.02% | 603 |
|
|
2021
Q3 | $112M | Buy |
2,315,305
+264,840
| +13% | +$13.5M | 0.02% | 789 |
|
|
2021
Q2 | $108M | Sell |
2,050,465
-521,015
| -20% | -$27.2M | 0.01% | 809 |
|
|
2021
Q1 | $127M | Sell |
2,571,480
-1,280,940
| -33% | -$61.5M | 0.02% | 652 |
|
|
2020
Q4 | $187M | Buy |
3,852,420
+232,277
| +6% | +$11.5M | 0.03% | 494 |
|
|
2020
Q3 | $182M | Sell |
3,620,143
-463,153
| -11% | -$23.8M | 0.04% | 413 |
|
|
2020
Q2 | $208M | Sell |
4,083,296
-1,059,464
| -21% | -$51.5M | 0.05% | 347 |
|
|
2020
Q1 | $225M | Buy |
5,142,760
+460,930
| +10% | +$22.1M | 0.06% | 279 |
|
|
2019
Q4 | $235M | Sell |
4,681,830
-549,237
| -10% | -$25.7M | 0.05% | 335 |
|
|
2019
Q3 | $242M | Buy |
5,231,067
+2,085,632
| +66% | +$89.9M | 0.06% | 302 |
|
|
2019
Q2 | $136M | Buy |
3,145,435
+800,612
| +34% | +$34M | 0.04% | 458 |
|
|
2019
Q1 | $104M | Buy |
2,344,823
+230,734
| +11% | +$9.88M | 0.03% | 526 |
|
|
2018
Q4 | $91.8M | Buy |
2,114,089
+339,597
| +19% | +$15M | 0.03% | 552 |
|
|
2018
Q3 | $79.3M | Sell |
1,774,492
-469,267
| -21% | -$20M | 0.02% | 717 |
|
|
2018
Q2 | $89.8M | Sell |
2,243,759
-1,288,048
| -36% | -$50.7M | 0.02% | 620 |
|
|
2018
Q1 | $142M | Sell |
3,531,807
-897,418
| -20% | -$37.3M | 0.04% | 441 |
|
|
2017
Q4 | $190M | Buy |
4,429,225
+168,991
| +4% | +$7.79M | 0.05% | 365 |
|
|
2017
Q3 | $212M | Sell |
4,260,234
-970,986
| -19% | -$47M | 0.06% | 298 |
|
|
2017
Q2 | $251M | Buy |
5,231,220
+1,466,902
| +39% | +$70.1M | 0.08% | 277 |
|
|
2017
Q1 | $170M | Sell |
3,764,318
-431,510
| -10% | -$18.3M | 0.05% | 369 |
|
|
2016
Q4 | $170M | Buy |
4,195,828
+854,308
| +26% | +$33.7M | 0.06% | 359 |
|
|
2016
Q3 | $128M | Sell |
3,341,520
-215,156
| -6% | -$8.63M | 0.04% | 453 |
|
|
2016
Q2 | $149M | Sell |
3,556,676
-558,808
| -14% | -$22.9M | 0.05% | 382 |
|
|
2016
Q1 | $165M | Buy |
4,115,484
+454,512
| +12% | +$18.3M | 0.06% | 333 |
|
|
2015
Q4 | $156M | Buy |
3,660,972
+946,483
| +35% | +$43.5M | 0.06% | 351 |
|
|
2015
Q3 | $129M | Sell |
2,714,489
-413,585
| -13% | -$21.1M | 0.05% | 395 |
|
|
2015
Q2 | $155M | Sell |
3,128,074
-143,377
| -4% | -$7.27M | 0.05% | 380 |
|
|
2015
Q1 | $162M | Buy |
3,271,451
+830,658
| +34% | +$39.7M | 0.06% | 351 |
|
|
2014
Q4 | $111M | Buy |
2,440,793
+302,985
| +14% | +$14.7M | 0.04% | 471 |
|
|
2014
Q3 | $121M | Sell |
2,137,808
-40,362
| -2% | -$2.17M | 0.05% | 439 |
|
|
2014
Q2 | $116M | Buy |
2,178,170
+153,680
| +8% | +$8.16M | 0.05% | 460 |
|
|
2014
Q1 | $106M | Buy |
2,024,490
+329,614
| +19% | +$16.7M | 0.04% | 458 |
|
|
2013
Q4 | $90.9M | Sell |
1,694,876
-227,881
| -12% | -$11.8M | 0.04% | 492 |
|
|
2013
Q3 | $97.3M | Buy |
1,922,757
+249,541
| +15% | +$12.7M | 0.05% | 428 |
|
|
2013
Q2 | $86.2M | Buy |
+1,673,216
| New | +$89.2M | 0.04% | 445 |
|
Other funds holding SNY
MIP
BIP
Morgan Stanley's SNY Position: Q2 2026 in Review
Morgan Stanley reduced its Sanofi (SNY) stake by 14% in Q2 2026, selling an estimated $80.8M and leaving 10,702,527 shares worth $457M. The position accounts for 0.02% of the portfolio, ranked #614.
Morgan Stanley first reported a position in SNY in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.02B in Q3 2024. 714 funds tracked by Wall St. Rank hold SNY as of Q2 2026.
- Morgan Stanley held 10,702,527 shares of Sanofi worth $457M as of Q2 2026.
- Morgan Stanley sold 1,809,340 Sanofi shares in Q2 2026, an estimated $80.8M.
- Sanofi made up 0.02% of Morgan Stanley's portfolio in Q2 2026, its #614 holding.
- Morgan Stanley first reported a position in Sanofi in Q2 2013 and has held it in 53 quarters since.
- Morgan Stanley's Sanofi position peaked at $1.02B in Q3 2024.
- 714 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.